Cancer Immunotherapy Drug Discovery Outsourcing Market Size, Revenue, Growth, Trend & Forecast Analysis, 2020 - 2027, By Cancer Type, By Service Type, By Drug Type, By Country, & By Region

  • Report Id: HCDHR 2160
  • Published Date: August, 2020
  • No of Pages: 150
  • Format: Electronic (PDF)
  • Publisher: DataHorizzon Research
  • Category:

Cancer Immunotherapy Drug Discovery Outsourcing Market Report Overview

Cancer immunotherapy drug discovery outsourcing market garnered a revenue of USD 720.7 million in the year 2019 globally and has been foreseen to yield USD 1,982.4 million by the year 2027 at a compound annual growth (CAGR) of 14.3% over the forecast period. The market has been observed to be growing at a steady growth rate over the last three years, however with the impact of COVID-19 pandemic globally, the business conditions are expected to change. The market size may reduce significantly or increase with a spike depending on how the value chain has been affected in the entire process.

Players that are operational in the market for a longer period of time are anticipated to absorb the sudden changes, losses and increased operational costs better than those who have recently entered the market. The report focuses on numerous factors that are anticipated to impact the market growth directly and indirectly. The report categorically analyses the growth patterns of different segments based on multiple derivation models.

Both the qualitative and quantitative aspects have been covered under the report. The Cancer Immunotherapy Drug Discovery Outsourcing market report includes market size, drivers, restraints, opportunities and trends that will help you understand the market dynamics in detail. Moreover, the report will include market estimates & forecasts in terms of revenue for the overall market along with the segments mentioned in the study. The report focuses on providing a holistic view of the entire market scenario from multiple unmatched detailed analysis mentioned in the report.

What to expect from the report?

  • Cancer Immunotherapy Drug Discovery Outsourcing Total Available Market (TAM)Size
  • Cancer Immunotherapy Drug Discovery Outsourcing Serviceable Available Market (SAM) Size
  • Business Implications of COVID-19 on the Overall Market
  • Market Share/ Revenue Share (%) of Top Market Players in Total Market Size (2019)
  • Market Size & Forecast (2016-2027) At Country & Regional Level, By Segments
  • Overview & Analysis of Key Players Operating in the Market

Key Highlights:

Parameters

Description

COVID-19

Impact of COVID-19 on overall business scenario

Cancer Immunotherapy Drug Discovery Outsourcing Market Revenue 2020

Global market revenue in 2020 will be derived taking into various micro & macro level factors; along with COVID-19 pandemic

Competitive Analysis

Company Market Share Analysis, 2019 (%)

Supply Chain Analysis

Analysis pertaining to several participants of supply chain such as raw material suppliers, distributors, & OEMs along with others will be highlighted in the study

Data Source

Primary & Secondary Research, Internal Data Base & Company Annual Reports

Regions Included

North America, Europe, Asia Pacific, Latin America, & Middle East & Africa

Countries Included

U.S., Canada, U.K., Germany, France, Mexico, Brazil, China, India, Japan, South Korea, UAE, South Africa

Table of Contents
Chapter 1. Research Methodology & Data Sources
1.1. Data Analysis Models
1.2. Research Scope & Assumptions
1.3. List of Primary & Secondary Data Sources
Chapter 2. Executive Summary
Chapter 3. Cancer Immunotherapy Drug Discovery Outsourcing Market: Industry Analysis
3.1. Market segmentation
3.2. Supply chain analysis
3.3. Porter’s 5 forces analysis
3.4. PEST analysis
3.5. Market Dynamics
3.5.1. Market driver analysis
3.5.2. Market restraint analysis
3.5.3. Market opportunity analysis
3.6. Company Market Share Analysis, 2019
Chapter 4. Cancer Immunotherapy Drug Discovery Outsourcing Market: Cancer Type Insights
4.1. Global Cancer Type Historic Market Data & Future Forecasts, 2016-2027
4.2. Lung Cancer
4.2.1. Historic Market Data & Future Forecasts, 2016-2027
4.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.3. Breast Cancer
4.3.1. Historic Market Data & Future Forecasts, 2016-2027
4.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.4. Colorectal Cancer
4.4.1. Historic Market Data & Future Forecasts, 2016-2027
4.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.5. Melanoma
4.5.1. Historic Market Data & Future Forecasts, 2016-2027
4.5.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.6. Prostate Cancer
4.6.1. Historic Market Data & Future Forecasts, 2016-2027
4.6.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 5. Cancer Immunotherapy Drug Discovery Outsourcing Market: Service Type Insights
5.1. Global Service Type Historic Market Data & Future Forecasts, 2016-2027
5.2. Target Identification and Validation
5.2.1. Historic Market Data & Future Forecasts, 2016-2027
5.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.3. Lead Screening and Characterization
5.3.1. Historic Market Data & Future Forecasts, 2016-2027
5.3.2. Historic Market Data & Future Forecasts, By Region, 2016-2027
5.4. Cell Bases Assays
5.4.1. Historic Market Data & Future Forecasts, 2016-2027
5.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 6. Cancer Immunotherapy Drug Discovery Outsourcing Market: Drug Type Insights
6.1. Global Drug Type Historic Market Data & Future Forecasts, 2016-2027
6.2. Monoclonal Antibodies
6.2.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
6.3. Immunomodulators
6.3.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.2. Historic Market Data & Future Forecasts, By Region, 2016-2027
6.4. Oncolytic Viral Therapies and Cancer Vaccines
6.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
6.5. Others
6.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 7. Cancer Immunotherapy Drug Discovery Outsourcing Market: Regional Insights
7.1. Global Cancer Immunotherapy Drug Discovery OutsourcingMarket Data & Future Forecasts, By Region 2016-2027
7.2. North America
7.2.1. Historic Market Data & Future Forecasts, 2016-2027
7.2.2. Historic Market Data & Future Forecasts, By Cancer Type, 2016-2027
7.2.3. Historic Market Data & Future Forecasts, By Service Type, 2016-2027
7.2.4. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.2.5. U.S.
7.2.5.1. Historic Market Data & Future Forecasts, 2016-2027
7.2.5.2. Historic Market Data & Future Forecasts, By Cancer Type, 2016-2027
7.2.5.3. Historic Market Data & Future Forecasts, By Service Type, 2016-2027
7.2.5.4. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.2.6. Canada
7.2.6.1. Historic Market Data & Future Forecasts, 2016-2027
7.2.6.2. Historic Market Data & Future Forecasts, By Cancer Type, 2016-2027
7.2.6.3. Historic Market Data & Future Forecasts, By Service Type, 2016-2027
7.2.6.4. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.3. Europe
7.3.1. Historic Market Data & Future Forecasts, 2016-2027
7.3.2. Historic Market Data & Future Forecasts, By Cancer Type, 2016-2027
7.3.3. Historic Market Data & Future Forecasts, By Service Type, 2016-2027
7.3.4. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.3.5. U.K.
7.3.5.1. Historic Market Data & Future Forecasts, 2016-2027
7.3.5.2. Historic Market Data & Future Forecasts, By Cancer Type, 2016-2027
7.3.5.3. Historic Market Data & Future Forecasts, By Service Type, 2016-2027
7.3.5.4. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.3.6. Germany
7.3.6.1. Historic Market Data & Future Forecasts, 2016-2027
7.3.6.2. Historic Market Data & Future Forecasts, By Cancer Type, 2016-2027
7.3.6.3. Historic Market Data & Future Forecasts, By Service Type, 2016-2027
7.3.6.4. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.3.7. France
7.3.7.1. Historic Market Data & Future Forecasts, 2016-2027
7.3.7.2. Historic Market Data & Future Forecasts, By Cancer Type, 2016-2027
7.3.7.3. Historic Market Data & Future Forecasts, By Service Type, 2016-2027
7.3.7.4. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.4. Asia Pacific
7.4.1. Historic Market Data & Future Forecasts, 2016-2027
7.4.2. Historic Market Data & Future Forecasts, By Cancer Type, 2016-2027
7.4.3. Historic Market Data & Future Forecasts, By Service Type, 2016-2027
7.4.4. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.4.5. China
7.4.5.1. Historic Market Data & Future Forecasts, 2016-2027
7.4.5.2. Historic Market Data & Future Forecasts, By Cancer Type, 2016-2027
7.4.5.3. Historic Market Data & Future Forecasts, By Service Type, 2016-2027
7.4.5.4. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.4.6. India
7.4.6.1. Historic Market Data & Future Forecasts, 2016-2027
7.4.6.2. Historic Market Data & Future Forecasts, By Cancer Type, 2016-2027
7.4.6.3. Historic Market Data & Future Forecasts, By Service Type, 2016-2027
7.4.6.4. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.4.7. Japan
7.4.7.1. Historic Market Data & Future Forecasts, 2016-2027
7.4.7.2. Historic Market Data & Future Forecasts, By Cancer Type, 2016-2027
7.4.7.3. Historic Market Data & Future Forecasts, By Service Type, 2016-2027
7.4.7.4. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.4.8. South Korea
7.4.8.1. Historic Market Data & Future Forecasts, 2016-2027
7.4.8.2. Historic Market Data & Future Forecasts, By Cancer Type, 2016-2027
7.4.8.3. Historic Market Data & Future Forecasts, By Service Type, 2016-2027
7.4.8.4. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.5. Latin America
7.5.1. Historic Market Data & Future Forecasts, 2016-2027
7.5.2. Historic Market Data & Future Forecasts, By Cancer Type, 2016-2027
7.5.3. Historic Market Data & Future Forecasts, By Service Type, 2016-2027
7.5.4. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.5.5. Brazil
7.5.5.1. Historic Market Data & Future Forecasts, 2016-2027
7.5.5.2. Historic Market Data & Future Forecasts, By Cancer Type, 2016-2027
7.5.5.3. Historic Market Data & Future Forecasts, By Service Type, 2016-2027
7.5.5.4. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.5.6. Mexico
7.5.6.1. Historic Market Data & Future Forecasts, 2016-2027
7.5.6.2. Historic Market Data & Future Forecasts, By Cancer Type, 2016-2027
7.5.6.3. Historic Market Data & Future Forecasts, By Service Type, 2016-2027
7.5.6.4. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.6. Middle East & Africa
7.6.1. Historic Market Data & Future Forecasts, 2016-2027
7.6.2. Historic Market Data & Future Forecasts, By Cancer Type, 2016-2027
7.6.3. Historic Market Data & Future Forecasts, By Service Type, 2016-2027
7.6.4. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.6.5. UAE
7.6.5.1. Historic Market Data & Future Forecasts, 2016-2027
7.6.5.2. Historic Market Data & Future Forecasts, By Cancer Type, 2016-2027
7.6.5.3. Historic Market Data & Future Forecasts, By Service Type, 2016-2027
7.6.5.4. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
7.6.6. South Africa
7.6.6.1. Historic Market Data & Future Forecasts, 2016-2027
7.6.6.2. Historic Market Data & Future Forecasts, By Cancer Type, 2016-2027
7.6.6.3. Historic Market Data & Future Forecasts, By Service Type, 2016-2027
7.6.6.4. Historic Market Data & Future Forecasts, By Drug Type, 2016-2027
Chapter 8. Company Profiles
8.1. Crown Bioscience Inc.
8.1.1. Company Description
8.1.2. Financial Highlights
8.1.3. Product Portfolio
8.1.4. Strategic Initiatives
8.2. Horizon Discovery Group plc
8.2.1. Company Description
8.2.2. Financial Highlights
8.2.3. Product Portfolio
8.2.4. Strategic Initiatives
8.3. Aquila Biomedical
8.3.1. Company Description
8.3.2. Financial Highlights
8.3.3. Product Portfolio
8.3.4. Strategic Initiatives
8.4. Explicit Immuno-Oncology
8.4.1. Company Description
8.4.2. Financial Highlights
8.4.3. Product Portfolio
8.4.4. Strategic Initiatives
8.5. Celentyx Ltd.
8.5.1. Company Description
8.5.2. Financial Highlights
8.5.3. Product Portfolio
8.5.4. Strategic Initiatives
8.6. Gen script Biotech Corporation
8.6.1. Company Description
8.6.2. Financial Highlights
8.6.3. Product Portfolio
8.6.4. Strategic Initiatives
8.7. BPS Biosciences Inc.
8.7.1. Company Description
8.7.2. Financial Highlights
8.7.3. Product Portfolio
8.7.4. Strategic Initiatives
8.8. HD Biosciences Co. Ltd.
8.8.1. Company Description
8.8.2. Financial Highlights
8.8.3. Product Portfolio
8.8.4. Strategic Initiatives
8.9. Promega Corporation
8.9.1. Company Description
8.9.2. Financial Highlights
8.9.3. Product Portfolio
8.9.4. Strategic Initiatives
8.10. Personalis
8.10.1. Company Description
8.10.2. Financial Highlights
8.10.3. Product Portfolio
8.10.4. Strategic Initiatives

List of Tables
Table 1 Cancer Immunotherapy Drug Discovery Outsourcing MarketMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 2 Cancer Immunotherapy Drug Discovery OutsourcingMarket Data & Future Forecasts, By Region, 2016-2027 (USD Million)
Table 3 Cancer Immunotherapy Drug Discovery OutsourcingMarket Data & Future Forecasts, By Cancer Type, 2016-2027 (USD Million)
Table 4 Cancer Immunotherapy Drug Discovery OutsourcingMarket Data & Future Forecasts, By Service Type, 2016-2027 (USD Million)
Table 5 Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Million)
Table 6 Lung CancerMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 7 Breast CancerMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 8 Colorectal CancerMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 9 Melanoma Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 10 Prostate CancerMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 11 Target Identification and ValidationMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 12 Lead Screening and Characterization Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 13 Cell Bases Assays Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 14 Monoclonal AntibodiesMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 15 ImmunomodulatorsMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 16 Oncolytic Viral Therapies and Cancer VaccinesMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 17 OthersMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 18 North America Cancer Immunotherapy Drug Discovery OutsourcingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 19 North America Cancer Immunotherapy Drug Discovery OutsourcingMarket Data & Future Forecasts, By Cancer Type, 2016-2027 (USD Million)
Table 20 North America Cancer Immunotherapy Drug Discovery OutsourcingMarket Data & Future Forecasts, By Service Type, 2016-2027 (USD Million)
Table 21 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Million)
Table 22 U.S. Cancer Immunotherapy Drug Discovery OutsourcingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 23 U.S. Cancer Immunotherapy Drug Discovery OutsourcingMarket Data & Future Forecasts, By Cancer Type, 2016-2027 (USD Million)
Table 24 U.S. Cancer Immunotherapy Drug Discovery OutsourcingMarket Data & Future Forecasts, By Service Type, 2016-2027 (USD Million)
Table 25 U.S. Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Million)
Table 26 Canada Cancer Immunotherapy Drug Discovery OutsourcingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 27 Canada Cancer Immunotherapy Drug Discovery OutsourcingMarket Data & Future Forecasts, By Cancer Type, 2016-2027 (USD Million)
Table 28 Canada Cancer Immunotherapy Drug Discovery OutsourcingMarket Data & Future Forecasts, By Service Type, 2016-2027 (USD Million)
Table 29 Canada Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Million)
Table 30 Europe Cancer Immunotherapy Drug Discovery OutsourcingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 31 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Cancer Type, 2016-2027 (USD Million)
Table 32 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Service Type, 2016-2027 (USD Million)
Table 33 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Million)
Table 34 U.K. Cancer Immunotherapy Drug Discovery OutsourcingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 35 U.K Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Cancer Type, 2016-2027 (USD Million)
Table 36 U.K Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Service Type, 2016-2027 (USD Million)
Table 37 U.K Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Million)
Table 38 Germany Cancer Immunotherapy Drug Discovery OutsourcingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 39 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Cancer Type, 2016-2027 (USD Million)
Table 40 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Service Type, 2016-2027 (USD Million)
Table 41 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Million)
Table 42 France Cancer Immunotherapy Drug Discovery OutsourcingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 43 France Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Cancer Type, 2016-2027 (USD Million)
Table 44 France nada Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Service Type, 2016-2027 (USD Million)
Table 45 France Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Million)
Table 46 Asia Pacific Cancer Immunotherapy Drug Discovery OutsourcingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 47 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Cancer Type, 2016-2027 (USD Million)
Table 48 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Service Type, 2016-2027 (USD Million)
Table 49 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Million)
Table 50 China Cancer Immunotherapy Drug Discovery OutsourcingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 51 China Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Cancer Type, 2016-2027 (USD Million)
Table 52 China Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Service Type, 2016-2027 (USD Million)
Table 53 China Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Million)
Table 54 India Cancer Immunotherapy Drug Discovery OutsourcingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 55 India Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Cancer Type, 2016-2027 (USD Million)
Table 56 India Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Service Type, 2016-2027 (USD Million)
Table 57 India Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Million)
Table 58 Japan Cancer Immunotherapy Drug Discovery OutsourcingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 59 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Cancer Type, 2016-2027 (USD Million)
Table 60 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Service Type, 2016-2027 (USD Million)
Table 61 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Million)
Table 62 South Korea Cancer Immunotherapy Drug Discovery OutsourcingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 63 South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Cancer Type, 2016-2027 (USD Million)
Table 64 South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Service Type, 2016-2027 (USD Million)
Table 65 South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Million)
Table 66 Latin America Cancer Immunotherapy Drug Discovery OutsourcingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 67 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Cancer Type, 2016-2027 (USD Million)
Table 68 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Service Type, 2016-2027 (USD Million)
Table 69 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Million)
Table 70 Brazil Cancer Immunotherapy Drug Discovery OutsourcingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 71 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Cancer Type, 2016-2027 (USD Million)
Table 72 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Service Type, 2016-2027 (USD Million)
Table 73 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Million)
Table 74 Mexico Cancer Immunotherapy Drug Discovery OutsourcingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 75 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Cancer Type, 2016-2027 (USD Million)
Table 76 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Service Type, 2016-2027 (USD Million)
Table 77 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Million)
Table 78 Middle East & Africa Cancer Immunotherapy Drug Discovery OutsourcingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 79 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Cancer Type, 2016-2027 (USD Million)
Table 80 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Service Type, 2016-2027 (USD Million)
Table 81 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Million)
Table 82 UAE Cancer Immunotherapy Drug Discovery OutsourcingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 83 UAE Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Cancer Type, 2016-2027 (USD Million)
Table 84 UAE Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Service Type, 2016-2027 (USD Million)
Table 85 UAE Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Million)
Table 86 South Africa Cancer Immunotherapy Drug Discovery OutsourcingMarket Data & Future Forecasts, 2016-2027 (USD Million)
Table 87 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Cancer Type, 2016-2027 (USD Million)
Table 88 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Service Type, 2016-2027 (USD Million)
Table 89 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Data & Future Forecasts, By Drug Type, 2016-2027 (USD Million)

List of Figures
Fig.1 Data Analysis Model
Fig.2Cancer Immunotherapy Drug Discovery Outsourcing Market, by 2016-2027 (USD Million)
Fig.3Cancer Immunotherapy Drug Discovery Outsourcing Market Segmentation
Fig.4Supply chain analysis
Fig.5 Cancer Immunotherapy Drug Discovery Outsourcing Market Driver Anlaysis
Fig.6 Cancer Immunotherapy Drug Discovery Outsourcing Market Restraint Analysis
Fig.7 Cancer Immunotherapy Drug Discovery Outsourcing Market Opportunity Analysis
Fig.8 Porters 5 Forces Model
Fig.9 PEST Analysis- Cancer Immunotherapy Drug Discovery Outsourcing Market
Fig.10 Company Market Share Analysis, 2019

Cancer Immunotherapy Drug Discovery Outsourcing Market Segmentation:

Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cancer Type (2016-2027)

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Melanoma
  • Prostate Cancer
  • Head and Neck Cancer
  • Ovarian Cancer
  • Pancreatic Cancer

Cancer Immunotherapy Drug Discovery Outsourcing Market, By Service Type (2016-2027)

  • Target Identification and Validation
  • Lead Screening and Characterization
  • Cell Bases Assays

Cancer Immunotherapy Drug Discovery Outsourcing Market, By Drug Type (2016-2027)

  • Monoclonal Antibodies
  • Immunomodulators
  • Oncolytic Viral Therapies and Cancer Vaccines
  • Others

Cancer Immunotherapy Drug Discovery Outsourcing Market, By Region (2016-2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • South Africa

Major Players Operating in the Cancer Immunotherapy Drug Discovery Outsourcing Market:

  • Crown Bioscience Inc.
  • Horizon Discovery Group plc
  • Aquila Biomedical
  • Explicit Immuno-Oncology
  • Celentyx Ltd.
  • Gen script Biotech Corporation
  • BPS Biosciences Inc.
  • HD Biosciences Co. Ltd.
  • Promega Corporation
  • Personalis

Choose License Type

Single user
$3,960
Multi User
$4,950
Enterprise User
$5,940
Clear

Each market study on Reports Globe will be revised based on COVID-19 impact analysis

How can we help you?

Our salient features

Best Solution

We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.

Customized Research

Our team of analysts and consultants provide assistance for customized research requirements

Max ROI

Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.

24/7 Support

24X7 availability to help you through the buying process as well as answer any of your doubts.

We've Received Your Request

We Thank You for filling out your requirements. Our sales team will get in touch with you shortly.